FLURBIPROFEN 0.03%w/v IP + BENZALKONIUM CHLORIDE 0.002%v/v IP

An analgesic ophthalmic solution for the treatment of ocular inflammations and prevents narrowing of the pupil during eye surgery. A class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs) relieves post-operative inflammation of the eye. Inhibits chemical substances that cause inflammation, pain, and irritation in the eye. Provides postsurgical anti-inflammatory efficacy in clinical signs of inflammation and blood-aqueous barrier disruption. A well-tolerated and safe topical medication that reduces inflammation for cataract surgery. (I Koçak, 1998) Protects the blood-aqueous barrier in human eyes during cataract surgery and intraocular lens implantation. (M Diestelhorst, 1991) More effective than indomethacin in maintaining a larger pupillary diameter in extracapsular cataract extraction. (M S Sachdev, 1990) Maintains adequate trans-operative pupillary dilatation during cataract surgery. (Saumya Sarkar, 2015) Shows a better and more prolonged mydriatic effect than Dexamethasone acetate 0.1% in preventing surgically induced miosis. (Mahdy, 2011) Exhibits superiority in maintaining mydriasis during cataract surgery than Diclofenac 0.1%. (K Psilas, 1992)